{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/prostatitis-acute/","result":{"data":{"firstChapter":{"id":"8803a04f-6c62-5033-ac75-2e0987df1dd9","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field b03e4b36-be96-4ff6-b271-4d15cdd464b7 --><h1>Prostatitis - acute: Summary</h1><!-- end field b03e4b36-be96-4ff6-b271-4d15cdd464b7 -->","htmlStringContent":"<!-- begin item db6529be-a744-42d2-9681-d9ca16d7fc36 --><!-- begin field b435b139-ff7f-4f4a-b959-2f66025c7441 --><ul><li>Acute bacterial prostatitis is a severe, potentially life-threatening bacterial infection of the prostate.<ul><li>Urinary infection with pathogens may be caused by urethral instrumentation, trauma, bladder outflow obstruction, or dissemination of infection from outside the urinary tract.</li><li>Most men treated appropriately for acute prostatitis will recover completely within 2 weeks.</li></ul></li><li>Acute prostatitis should be suspected in a man who presents with signs and symptoms of:<ul><li>A urinary tract infection (UTI) — dysuria, frequency, urgency.</li><li>Prostatitis — perineal, penile, or rectal pain; acute urinary retention, obstructive voiding symptoms; low back pain, pain on ejaculation; tender, swollen, warm prostate (on gentle rectal examination).</li><li>Bacteraemia — rigors, arthralgia, or myalgia; fever, tachycardia. </li></ul></li><li>Assessment of men suspected of having bacterial prostatitis includes: <ul><li>Collecting a mid-steam urine (MSU) sample to confirm UTI by dipstick, culture and sensitivity.</li><li>Arranging blood cultures and full blood count.</li><li>Conducting a physical examination — this should include the abdomen to detect a distended bladder and costovertebral angle tenderness, a genital examination, and a digital rectal examination (DRE).</li><li>Considering screening for sexually transmitted infections (STIs), particularly in men considered to be at risk. </li><li>Considering and excluding other diagnoses. </li></ul></li><li>Men suspected of having acute bacterial prostatitis should be prescribed an oral antibiotic for 14 days: ciprofloxacin 500 mg twice daily or ofloxacin 200 mg twice daily first line, or if they are unsuitable trimethoprim 200 mg twice daily. Second-line options should include levofloxacin 500 mg once daily, or co-trimoxazole 960 mg twice daily. </li><li>Men should be advised:<ul><li>To take paracetamol (with or without a low-dose weak opioid, such as codeine) for pain, or ibuprofen if this is preferred and suitable.</li><li>To drink enough fluids to avoid dehydration. </li><li>About the usual course of acute prostatitis (several weeks).</li><li>About possible adverse effects of the antibiotic.</li><li>To seek medical help if symptoms worsen at any time, symptoms do not start to improve within 48 hours of taking the antibiotic, or they become systemically very unwell.</li></ul></li><li>Follow up should be arranged after 48 hours to check response to treatment and the urine culture results.<ul><li>Antibiotic choice should be reviewed and changed according to susceptibility results if the bacteria are resistant.</li><li>Admission to hospital should be arranged if symptoms have not improved 48 hours after starting antibiotic treatment.</li><li>Urgent referral to to a genito-urinary medicine (GUM) clinic should be arranged if an STI is identified.</li></ul></li><li>Antibiotic treatment should be reviewed after 14 days.</li><li>Following recovery, men should be referred for investigation<strong> </strong>to exclude structural abnormality of the urinary tract. </li><li>Admission to hospital should be arranged if the man:<ul><li>Is unable to take oral antibiotics. </li><li>Has severe symptoms. </li><li>Has signs or symptoms of a more serious condition (for example sepsis, acute urinary retention or prostatic abscess). </li></ul></li><li>Urgent referral should be considered for any man who:<ul><li>Is immunocompromised or has diabetes mellitus. </li><li>Has a pre-existing urological condition (such as benign prostatic hypertrophy or an indwelling catheter) — specialist urological management may be required. </li></ul></li></ul><!-- end field b435b139-ff7f-4f4a-b959-2f66025c7441 --><!-- end item db6529be-a744-42d2-9681-d9ca16d7fc36 -->","topic":{"id":"73f0b35c-c49b-5f10-bb40-54ecdda0c994","topicId":"e7655eee-79f9-435e-b34e-7e3dc9576eb5","topicName":"Prostatitis - acute","slug":"prostatitis-acute","aliases":[],"chapters":[{"id":"8803a04f-6c62-5033-ac75-2e0987df1dd9","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"23265380-0c8c-51f6-984e-87cbf6e27684","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7f11e55f-ca93-5c30-86f8-fa21b370c650","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"aa21e1cb-1af6-5deb-b54b-9cb7a12a8a11","slug":"changes","fullItemName":"Changes"},{"id":"bc4d0c33-79f0-5fe0-8655-d9dbf99bbcf5","slug":"update","fullItemName":"Update"}]},{"id":"e29f027b-46a8-5ac6-b1b7-d063f673588e","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"e0a59bba-34f6-512a-b3f6-19ba509165b0","slug":"goals","fullItemName":"Goals"},{"id":"b99f36b6-4383-55b0-8d6f-72dfeed4d249","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"0629bcf7-67ce-5175-893c-bb0e770c16c1","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6da14859-d882-5bd2-b686-021dc2ab43ca","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"90fb5a5f-3ae5-53d9-b871-bf93c899f97c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a78a1b88-9559-551a-880f-736efedb2497","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"c8ae728c-472f-509a-add8-39034e05aff0","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"816a1fba-211e-520e-87c1-c47a23e06dd3","slug":"definition","fullItemName":"Definition"},{"id":"42efdea9-f709-5243-8b5c-a2b75dbbba5f","slug":"causes","fullItemName":"Causes"},{"id":"9713a2ac-cc24-5443-9756-3e59fbcf65b8","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d981ad36-33da-56db-bb45-f12d69fe5543","slug":"prognosis","fullItemName":"Prognosis"},{"id":"5b0439a7-9599-542f-b2b2-51d20cc566f2","slug":"complications","fullItemName":"Complications"}]},{"id":"6553966d-798f-5d17-bcd0-6f62f2f8b5bd","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"d539bec4-2427-585f-a83c-db984fc0d801","slug":"suspecting-acute-prostatitis","fullItemName":"Suspecting acute prostatitis"},{"id":"d1e691e6-d634-508e-a5c1-62018b5b24be","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"2e7dc7c5-dc32-59bf-9021-54b838ce5a9b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"398acafd-0ba3-5cf1-8c9c-8d2ccca863ae","slug":"management","fullItemName":"Management","subChapters":[{"id":"8c56415b-f5bc-5fc1-b859-13b369ee963d","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"50977f3d-5737-50f5-9c23-c4a03b4539cf","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"c6f0cb41-8824-5f6b-9b63-19a56232237a","slug":"ciprofloxacin","fullItemName":"Ciprofloxacin"},{"id":"161382aa-bad2-5c17-9d1c-59f978dd6a83","slug":"ofloxacin","fullItemName":"Ofloxacin"},{"id":"6aee14ab-550d-5bdd-b0e4-d2febce26f7a","slug":"trimethoprim","fullItemName":"Trimethoprim"},{"id":"7fc380fc-24a6-5224-9d35-019f77e2d24e","slug":"levofloxacin","fullItemName":"Levofloxacin"},{"id":"fc84b330-890f-5ebf-b2cd-5724765b85a8","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"}]},{"id":"c4981733-d5d6-5190-b43d-7cdee7ac825c","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"137ffbc9-e5c4-5f58-bfc1-4d3afb883356","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"5f07d427-7c9b-521d-ba7a-1a7bc564f48d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"05f5c8e4-6073-506c-909a-cef5c3cf622c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"63ca9076-27d4-5254-9eda-bcbb43177d95","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ff474396-1f31-58cd-b153-976c3894cafd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"be6b66c2-c9cc-5d52-99dd-044e49dadfb0","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9b5aeabb-1902-5659-8e0b-625f567b86e0","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"73f0b35c-c49b-5f10-bb40-54ecdda0c994","topicId":"e7655eee-79f9-435e-b34e-7e3dc9576eb5","topicName":"Prostatitis - acute","slug":"prostatitis-acute","aliases":[],"topicSummary":"Acute bacterial prostatitis is a potentially serious non-sexually transmitted bacterial infection of the prostate","lastRevised":"Last revised in November 2020","nextPlannedReviewBy":"2024-04-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2024-03","nextPlannedReviewByDisplay":"March 2024","specialities":[{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"},{"id":"f72b3ad6-0501-5364-8469-e48bd9b988b9","name":"Kidney disease and urology","slug":"kidney-disease-urology"},{"id":"34b90622-9d68-500d-98a2-3c80efbae845","name":"Men's health","slug":"mens-health"}],"chapters":[{"id":"8803a04f-6c62-5033-ac75-2e0987df1dd9","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"23265380-0c8c-51f6-984e-87cbf6e27684","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7f11e55f-ca93-5c30-86f8-fa21b370c650","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"aa21e1cb-1af6-5deb-b54b-9cb7a12a8a11","slug":"changes","fullItemName":"Changes"},{"id":"bc4d0c33-79f0-5fe0-8655-d9dbf99bbcf5","slug":"update","fullItemName":"Update"}]},{"id":"e29f027b-46a8-5ac6-b1b7-d063f673588e","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"e0a59bba-34f6-512a-b3f6-19ba509165b0","slug":"goals","fullItemName":"Goals"},{"id":"b99f36b6-4383-55b0-8d6f-72dfeed4d249","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"0629bcf7-67ce-5175-893c-bb0e770c16c1","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6da14859-d882-5bd2-b686-021dc2ab43ca","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"90fb5a5f-3ae5-53d9-b871-bf93c899f97c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a78a1b88-9559-551a-880f-736efedb2497","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"c8ae728c-472f-509a-add8-39034e05aff0","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"816a1fba-211e-520e-87c1-c47a23e06dd3","slug":"definition","fullItemName":"Definition"},{"id":"42efdea9-f709-5243-8b5c-a2b75dbbba5f","slug":"causes","fullItemName":"Causes"},{"id":"9713a2ac-cc24-5443-9756-3e59fbcf65b8","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d981ad36-33da-56db-bb45-f12d69fe5543","slug":"prognosis","fullItemName":"Prognosis"},{"id":"5b0439a7-9599-542f-b2b2-51d20cc566f2","slug":"complications","fullItemName":"Complications"}]},{"id":"6553966d-798f-5d17-bcd0-6f62f2f8b5bd","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"d539bec4-2427-585f-a83c-db984fc0d801","slug":"suspecting-acute-prostatitis","fullItemName":"Suspecting acute prostatitis"},{"id":"d1e691e6-d634-508e-a5c1-62018b5b24be","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"2e7dc7c5-dc32-59bf-9021-54b838ce5a9b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"398acafd-0ba3-5cf1-8c9c-8d2ccca863ae","slug":"management","fullItemName":"Management","subChapters":[{"id":"8c56415b-f5bc-5fc1-b859-13b369ee963d","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"50977f3d-5737-50f5-9c23-c4a03b4539cf","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"c6f0cb41-8824-5f6b-9b63-19a56232237a","slug":"ciprofloxacin","fullItemName":"Ciprofloxacin"},{"id":"161382aa-bad2-5c17-9d1c-59f978dd6a83","slug":"ofloxacin","fullItemName":"Ofloxacin"},{"id":"6aee14ab-550d-5bdd-b0e4-d2febce26f7a","slug":"trimethoprim","fullItemName":"Trimethoprim"},{"id":"7fc380fc-24a6-5224-9d35-019f77e2d24e","slug":"levofloxacin","fullItemName":"Levofloxacin"},{"id":"fc84b330-890f-5ebf-b2cd-5724765b85a8","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"}]},{"id":"c4981733-d5d6-5190-b43d-7cdee7ac825c","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"137ffbc9-e5c4-5f58-bfc1-4d3afb883356","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"5f07d427-7c9b-521d-ba7a-1a7bc564f48d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"05f5c8e4-6073-506c-909a-cef5c3cf622c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"63ca9076-27d4-5254-9eda-bcbb43177d95","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ff474396-1f31-58cd-b153-976c3894cafd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"be6b66c2-c9cc-5d52-99dd-044e49dadfb0","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9b5aeabb-1902-5659-8e0b-625f567b86e0","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"73f0b35c-c49b-5f10-bb40-54ecdda0c994"}},"staticQueryHashes":["3666801979"]}